COVID‐19 in solid organ transplant recipients: a single‐center experience

Citations Over TimeTop 10% of 2020 papers

Abstract

Solid organ transplant (SOT) recipients may be at risk for severe COVID-19. Data on the clinical course of COVID-19 in immunosuppressed patients are limited, and the effective treatment strategy for these patients is unknown. We describe our institutional experience with COVID-19 in SOT. Demographic, clinical, and treatment data were extracted from the electronic patient files. A total of 23 SOT transplant recipients suffering from COVID-19 were identified (n = 3 heart; n = 15 kidney; n = 1 kidney-after-heart; n = 3 lung, and n = 1 liver transplant recipient). The presenting symptoms were similar to nonimmunocompromised patients. Eighty-three percent (19/23) of the patients required hospitalization, but only two of these were transferred to the intensive care unit. Five patients died from COVID-19; all had high Clinical Frailty Scores. In four of these patients, mechanical ventilation was deemed futile. In 57% of patients, the immunosuppressive therapy was not changed and only three patients were treated with chloroquine. Most patients recovered without experimental antiviral therapy. Modification of the immunosuppressive regimen alone could be a therapeutic option for SOT recipients suffering from moderate to severe COVID-19. Pre-existent frailty is associated with death from COVID-19.

Related Papers

• → The Historical Link Between Solid-Organ Transplantation, Immunosuppression, and Skin Cancer(2004)29 cited
• → Investigation of the Relationship Between Oral Lesions and Early Pneumonia Associated with Mechanical Ventilation in Patients Undergoing Mechanical Ventilation in Intensive Care Unit(2016)1 cited
• → Factors associated with survival in patients undergoing invasive mechanical ventilation in an intensive care unit in Colombia v1(2020)1 cited
• → The Effect of Co-Morbid Diseases on The Need for Mechanical Ventilation and Mortality of Patients with Covid-19 in Intensive Care Unit(2021)1 cited
• → Anaplastic large cell lymphoma in an organ transplant recipient(2018)